Yatharth Hospital & Trauma Care Services enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
9,110————
22122143611337.4
——31.72.92.0
2532530.083.1264
9,143————
32.232.2−436−29.6226
₹948.85————
2,0602,0601,637957447
12.3%12.3%0.0%8.7%59.0%
0.03×————
6.85×————
29.46×————
43.69×————
Reference items — trailing FY values
1,3341,207880671372
310292220180105
20920416315192.7
—205150−3.163.8
−112−112−161−96.444.0
—−113−163−99.041.8
—31731193.419.8
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

YATHARTH₹945.50

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHMEDANTAFORTISVIYASHTHYROCARESUPRIYASTARSPARCMcap ₹9,110 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————9,110.3
- Cash, Equiv & ST Investments37.4112.7435.9221.1221.1
+ Minority Interest2.02.931.7——
+ Total Debt263.883.10.0253.3253.3
Enterprise Value————9,142.5
Net Debt (memo)226.3-29.6-435.932.232.2
EV per Share————948.85
Total Capital446.7957.41,637.12,060.52,060.5
Total Debt/Total Capital59.048.680.0012.2912.29
Total Debt/EV————0.03
EV/Sales————6.85
EV/EBITDA————29.46
EV/EBIT————43.69
Reference Items — Trailing FY Values
Sales371.5670.5880.51,207.21,334.1
EBITDA105.3179.9220.2292.1310.4
EBIT92.7150.6163.1204.3209.2
Operating Cash Flow63.8-3.1149.6204.5—
Free Cash Flow44.0-96.4-161.2-112.0-112.0
FCFF (free cash flow to the firm)41.8-99.0-163.0-112.9—
Capital Expenditure19.893.4310.8316.5—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.